Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRC375 in Moderate to Severe Rheumatoid Arthritis
NCT01408602Phase 2Unknown
- Sponsor
- Molecular Research Center
- Start
- Nov 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetracycline in rheumatoid arthritis (RA), sponsored by Molecular Research Center. Status: unknown.
02
Drugs
tetracycline
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01408602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01408602.